A new breast cancer drug that could help increase survival rates has been approved.
Perjeta has been trialled at the Christie Hospital in Manchester.
Doctors found that, combined with other drugs and chemotherapy, it could extend the lives of thousands of patients.
Now it could be introduced across the country.
Elaine Willcox reports.
More detail on the new breast cancer drug Perjeta, that was trialled on patients in Manchester
Breast cancer charities have welcomed a new drug which can extend the life of some women who have an advanced form of the disease